SHALBY
|
|
BOM : 540797     NSE : SHALBY     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : None or < 25% |
Apr 19,2024 |
Price(EOD): ₹ 266.70
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
MCap: ₹ 2,880.36 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
SHALBY | 3.8% | -18.1% | 98.3% |
APOLLO HOSPITALS ENTERPRISE | 3.4% | -6.6% | 49% |
MAX HEALTHCARE INSTITUTE | 5.7% | -8.7% | 59.1% |
GLOBAL HEALTH | 6.7% | -13.1% | 164.4% |
FORTIS HEALTHCARE | 2.6% | -6.4% | 59.4% |
NARAYANA HRUDAYALAYA | 2% | -9.6% | 59.5% |
ASTER DM HEALTHCARE | 1.9% | -6.1% | 86.2% |
DR LAL PATHLABS | 12.9% | -7.3% | 19.6% |
KRISHNA INSTITUTE OF MEDICAL SCIENCES | 3.3% | -8.3% | 51.4% |
FUNDAMENTAL ANALYSIS OF SHALBY
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF SHALBY
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
35.41
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 81.36 Cr
[Latest Qtr - Dec2023 - Consolidated Results ] 3.11
P/B Calculated based on Book Value of Rs 926.87 Cr
[Latest Year - Mar2023 - Consolidated Results ] 3.24
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 888.50 Cr
[Latest Qtr - Dec2023 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
104% 58% 30% |
SHARE PRICE MOMENTUM OF SHALBY
SHALBY vs SENSEX
DEBT OF SHALBY
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2023 2022 2021 Avg_3yrs |
0.03 0.05 0.05 0.04 |
0.15 0.18 0.05 0.13 |
[Last Annual Data : Mar2023]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF SHALBY
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF SHALBY
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-9.22% -19.71% -27.73% -30.87% |
6.71% 24.66% 30.9% 24.82% |
QtrlyTrend |
0 | |
Latest Qtr: Dec2023 | ||
Quarterly Result Analysis → |
SHALBY related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE SMALL CAP | -1.6% | 8.4% | 61.4% |
S&P BSE MIDSMALLCAP | -2.1% | 6.3% | 61.6% |
S&P BSE ALLCAP | -2.5% | 2.7% | 37.3% |
S&P BSE HEALTHCARE | -3.6% | 0.7% | 51.1% |
You may also like the below Video Courses
FAQ about SHALBY
Is SHALBY good for long term investment?
As on Apr 19,2024, the Fundamentals of SHALBY look Strong and hence it may be good for long term investment! See Financial Performance of SHALBY . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is SHALBY UnderValued or OverValued?
As on Apr 19,2024, SHALBY is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of SHALBY ?
As on Apr 19,2024, the Intrinsic Value of SHALBY is Rs. 168.29 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 130.69
Fair Value [Median EV / Sales Model] : Rs. 168.29
Fair Value [Median Price / Sales Model] : Rs. 205.92
Estimated Median Fair Value of SHALBY : Rs. 168.29
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.